PANGENOTYPIC NS5A PROTEIN INHIBITOR OF HEPATITIS C VIRUS, A PHARMACEUTICAL COMPOSITION AND METHODS FOR PREPARING AND USING Russian patent published in 2020 - IPC C07D403/14 A61K31/4178 A61P1/16 

Abstract RU 2723482 C1

FIELD: chemistry.

SUBSTANCE: invention relates to organic chemistry and specifically to a compound methyl [(1S)-1-{(2S)-2-[5-(4'-{2-[(2S)-1-{(2S,3R)-3-methoxy-2-[(methoxycarbonyl)amino]butanoyl}-pyrrolidin-2-yl]-1H-imidazol-5-yl}biphenyl-4-yl)-1H-imidazol-2-yl]pyrrolidin-1-yl}-2-methylpropyl]carbamate of formula 1 and its pharmaceutically acceptable salts

Also disclosed are methods of producing a compound of formula 1, a pharmaceutical composition based thereon and a method of treating hepatitis C.

EFFECT: obtaining a novel organic compound having the properties of a panthenotypic NS5A HCV inhibitor.

9 cl, 2 tbl, 7 ex

Similar patents RU2723482C1

Title Year Author Number
ALKYL [2-(2-{5-[4-(4-{2-[1-(2-METHOXYCARBONYLAMINO-ACETYL)-PYRROLIDIN-2-YL]-3H-IMIDAZOL-4-YL}-PHENYL)-BUTA-1,3-DIINYL]-1H-IMIDAZOL-2-YL}-PYRROLIDIN-1-YL)-2-OXO-ETHYL]-CARBAMATE, PHARMACEUTICAL COMPOSITION, MEDICATION, METHOD OF TREATING VIRAL DISEASES 2013
  • Ivashchenko Aleksandr Vasil'Evich
  • Mit'Kin Oleg Dmitrievich
RU2518369C1
ALKYL [(S)-1-((S)-2-{5-[4-(4-{2-[(S)-1-((S)-2-METHOXYCARBONYLAMINO-3-METHYL-BUTYRYL)-PYRROLIDIN-2-YL]-3H-IMIDAZOL-4-YL}-BUTA-1,3-DIINYL)-PHENYL]-1H-IMIDAZOL-2-YL}-PYRROLIDINE-1-CARBONYL)-2-METHYL-PROPYL]-CARBAMATE NAPHTHALENE-1,5-DISULPHONATE, PHARMACEUTICAL COMPOSITION, MEDICINAL AGENT, METHOD OF TREATING VIRAL DISEASES 2013
  • Ivashchenko Aleksandr Vasil'Evich
RU2507201C1
ANTIVIRAL COMPOSITION AND METHOD OF ITS APPLICATION 2017
  • Aleksandr Vasilevich Ivashchenko
  • Mitkin Oleg Dmitrievich
RU2650610C1
PAN-GENOMIC INHIBITORS OF THE HEPATITIS C VIRUS PROTEIN NS5A, PHARMACEUTICAL COMPOSITIONS, INTERMEDIATES FOR THE SYNTHESIS OF INHIBITORS, AND METHODS FOR THEIR PREPARATION AND USE 2016
  • Aleksandr Vasilevich Ivashchenko
  • Mitkin Oleg Dmitrievich
RU2669919C1
PRODRUG OF POLYMERASE NS5B HCV INHIBITOR, METHOD FOR ITS PREPARATION AND APPLICATION 2017
  • Ivashchenko Aleksandr Vasilevich
  • Mitkin Oleg Dmitrievich
RU2644156C1
NUCLEOTIDES INCLUDING N-[(S)-1-CYCLOBUTOXYCARBONYL]PHOSPHORAMIDATE FRAGMENT, THEIR ANALOGS AND THEIR APPLICATION 2017
  • Aleksandr Vasilevich Ivashchenko
  • Mitkin Oleg Dmitrievich
RU2659388C1
SUBSTITUTED AZOLES, ANTIVIRAL ACTIVE COMPONENT, PHARMACEUTICAL COMPOSITION, SYNTHESIS AND APPLICATION METHOD 2010
  • Ivashchenko Aleksandr Vasil'Evich
  • Bychko Vadim Vasil'Evich
  • Mit'Kin Oleg Dmitrievich
RU2452735C1
CYCLOBUTYL (S)-2-[[[R)-2-(6-AMINOPURIN-9-YL)-1-METHYL-ETOXY]METHYL-PHENOXY-PHOSPHORYL]AMINO]-PROPANOATES, METHOD OF THEIR PRODUCTION AND APPLICATION 2017
  • Aleksandr Vasilevich Ivashchenko
  • Mitkin Oleg Dmitrievich
RU2647576C1
ANELLATED 9-HYDROXY-1,8-DIOXO-1,3,4,8-TETRAHYDRO-2H-PYRIDO[1,2-A]PYRAZINE-7-CARBOXAMIDES - INTEGRASE INHIBITORS, METHODS FOR PREPARING AND USING THEREOF 2019
  • Ivashchenko Andrej Aleksandrovich
  • Ivashchenko Aleksandr Vasilevich
  • Mitkin Oleg Dmitrievich
  • Savchuk Nikolaj Filippovich
RU2717101C1
NUCLEOSIDE INHIBITORS OF RNA-POLYMERASE HCV NS5B, METHODS FOR PRODUCTION AND USE THEREOF 2014
  • Ivashchenko Aleksandr Vasil'Evich
RU2567854C1

RU 2 723 482 C1

Authors

Ivashchenko Andrej Aleksandrovich

Ivashchenko Aleksandr Vasilevich

Mitkin Oleg Dmitrievich

Dates

2020-06-11Published

2019-10-22Filed